Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

329 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-09-30

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with heroin and prescription opioid dependence are at increased risk for adverse health consequences and often utilize the Emergency Department (ED) as their source of medical care. Screening, brief intervention and referral to treatment has been effective in decreasing high risk behaviors such as alcohol and tobacco use, and unsafe sexual practices. The data on the effectiveness of brief interventions with opioid dependence is limited. This prospective, randomized controlled trial of opioid dependent subjects (N=360) will compare two models of brief intervention with a control condition. ED patients with opioid dependence will be randomized to either: (1)Screening, Brief Intervention with a Facilitated Referral to Treatment (SBIRT); (2) Screening, Brief Intervention with ED initiated Buprenorphine Treatment (SBI+Bup); or (3) standard care (SC) which includes a handout detailing substance abuse treatment centers in the area. The primary outcome will be self-reported engagement in formal substance abuse treatment at 30 days, verified by contact with the treatment program. Other outcomes measured at 30 days, 2, 6 and 12 months include changes in opioid use (self-report and urine toxicology analysis), HIV risk behaviors, and health care service utilization. The three interventions will also be compared on their cost-effectiveness. We will test the hypotheses that SBI+Bup will be superior to SBIRT and SC, and SBIRT will be superior to SC in (1)increasing the proportion of patients engaged in formal substance abuse treatment at 30 days; (2) reducing illicit opioid use; (3) reducing HIV risk behaviors; and (4) reducing health care service utilization. In addition, we hypothesize that the societal costs of SBI+Bup, per number of days of opioid abstinence, will be cost effective relative to SBIRT or SC; and that SBIRT will be cost effective relative to SC. Data analyses will be conducted on the intention to treat sample of randomized patients. This study, conducted by a research team with extensive experience evaluating brief interventions and treatments for opioid dependence, will be unique in its: (1) comparison of two models of brief intervention with standard care; (2) inclusion of an ED initiated treatment arm; (3) use of manual-guided interventions with systematic assessment of adherence and competence; and (4)collection of detailed cost data to help guide future healthcare policy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Emergency Department Outcomes for Patients With Opioid Use Disorder

NCT04289363

Opioid-use Disorder

COMPLETED

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

NCT00000231

Opioid-Related Disorders

COMPLETED PHASE2

Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder

NCT03544112

Opioid-use Disorder

COMPLETED

Opioid Use Disorder in the Emergency Department: CTN 0069

NCT03023930

Opioid Use Disorder

COMPLETED NA

Linking Opioid Dependent Patients From Inpatient Detoxification to Primary Care

NCT01751789

Illicit Opioid Drug Use

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opiate Addiction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SC

Standard Care

Group Type NO_INTERVENTION

No interventions assigned to this group

SBIRT

Screening, Brief Intervention and Facilitated Referral to Treatment

Group Type EXPERIMENTAL

Brief Negotiation Interview (BNI)

Intervention Type BEHAVIORAL

Brief Negotiation Interview (BNI) is a manual-guided therapy that is designed to be feasible in the ED setting. The purpose of the BNI is to assist patients in recognizing and changing their drug use and HIV risk behaviors. It combines techniques based on motivational interviewing and a stage-model of change. The main goal of the interview is to decrease the subject's ambivalence about signing up for a formal drug treatment program.

SBI+Bup

Screening, Brief Intervention and Buprenorphine initiation

Group Type EXPERIMENTAL

Brief Negotiation Interview (BNI)

Intervention Type BEHAVIORAL

Brief Negotiation Interview (BNI) is a manual-guided therapy that is designed to be feasible in the ED setting. The purpose of the BNI is to assist patients in recognizing and changing their drug use and HIV risk behaviors. It combines techniques based on motivational interviewing and a stage-model of change. The main goal of the interview is to decrease the subject's ambivalence about signing up for a formal drug treatment program.

Buprenorphine Initiation

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brief Negotiation Interview (BNI)

Brief Negotiation Interview (BNI) is a manual-guided therapy that is designed to be feasible in the ED setting. The purpose of the BNI is to assist patients in recognizing and changing their drug use and HIV risk behaviors. It combines techniques based on motivational interviewing and a stage-model of change. The main goal of the interview is to decrease the subject's ambivalence about signing up for a formal drug treatment program.

Intervention Type BEHAVIORAL

Buprenorphine Initiation

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who present to the adult ED at Yale-New Haven Hospital (YNHH) who are:

1. 18 years or older,
2. meet criteria for opioid dependence as measured by the Mini-SCID, and
3. have a positive urine toxicology for opiates.

Exclusion Criteria

* Inability to read or understand English
* Currently receiving formal substance abuse treatment
* Current suicide or homicidal risk
* Current psychotic disorder
* Life-threatening or unstable medical or psychiatric condition requiring hospital admission
* Unable to provide 2 phone contact numbers
* Unwilling to be randomized and/or follow up as per study protocol, including release of information to assess treatment engagement at 30-days
* Requiring opioid agonist medication for a pain-related diagnosis (contraindication to buprenorphine)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No